6.27
-0.13
(-2.03%)
At close: April 10 at 4:00:01 PM EDT
6.58
+0.31
+(4.94%)
After hours: April 10 at 5:55:05 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
AYNECHI TIBA Director | Purchase | Sep 16, 2024 | -- |
BASKETT FOREST Beneficial Owner of more than 10% of a Class of Security | Purchase | Sep 16, 2024 | -- |
BEHBAHANI ALI Beneficial Owner of more than 10% of a Class of Security | Purchase | Sep 16, 2024 | -- |
CORNELIUS JAMES M Director | Conversion of Exercise of derivative security | Sep 16, 2024 | 102,082 |
FLORENCE ANTHONY A JR Beneficial Owner of more than 10% of a Class of Security | Purchase | Sep 16, 2024 | -- |
GORDON CARL L Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Feb 18, 2025 | -- |
HAWRYLUK P KENT Chief Executive Officer | Purchase | Feb 4, 2025 | -- |
HERON PATRICK J Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Sep 16, 2024 | -- |
MATHERS EDWARD T. Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Sep 16, 2024 | -- |
ORBIMED ADVISORS, L.L.C. Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Feb 18, 2025 | -- |
Related Tickers
BCAX Bicara Therapeutics Inc.
10.15
-2.40%
DSGN Design Therapeutics, Inc.
2.7900
-5.90%
UPB Upstream Bio, Inc.
6.40
-1.99%
SEPN Septerna, Inc.
5.16
-8.02%
MAZE Maze Therapeutics, Inc.
7.60
-4.64%
CTNM Contineum Therapeutics, Inc.
4.1300
-10.61%
DNTH Dianthus Therapeutics, Inc.
15.60
-4.47%
AARD Aardvark Therapeutics, Inc. Common Stock
7.02
-9.88%
BOLD Boundless Bio, Inc.
1.1900
-0.83%
MLYS Mineralys Therapeutics, Inc.
12.19
-4.99%